Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10040202HBVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS10040086HBVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS30010849HIVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS20037373HPVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS20039601HPVENSG00000157404.17protein_codingKITYesNo3815P10721
TVIS44012431HTLV-1ENSG00000157404.17protein_codingKITYesNo3815P10721
TCGA Plot Options
Drug Information
GeneKIT
DrugBank IDDB08901
Drug NamePonatinib
Target IDBE0000453
UniProt IDP10721
Regulation Typeinhibitor
PubMed IDs23539538
CitationsGleixner KV, Peter B, Blatt K, Suppan V, Reiter A, Radia D, Hadzijusufovic E, Valent P: Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V. Haematologica. 2013 Sep;98(9):1450-7. doi: 10.3324/haematol.2012.079202. Epub 2013 Mar 28.
GroupsApproved; Investigational
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
PathwaysPonatinib Inhibition of BCR-ABL
PharmGKBPA165980594
ChEMBLCHEMBL1171837